Cystatin C also can be released by mouse oligodendrocytes overexpressing human α-synuclein, triggering α-synuclein up-regulation and insoluble α-synuclein accumulation in a transgenic mouse mode of MSA (Suzuki et al., 2014). The gene discussed is CST3; the disease is multiple system atrophy.